🗂️

Archived grant — no longer open

This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.

grant

NICHD: R&D: ANDROGENIC, ANABOLIC, AND PRECLINICAL SAFETY STUDIES: NON-SEVERABLE

Organization SRI INTERNATIONALLocation MENLO PARK, UNITED STATESPosted 1 Aug 2025Deadline 31 Jan 2026 ⚠️
NIHUS FederalResearch GrantFY2025ADME StudyAbsorption, Distribution, Metabolism, and Excretion StudyAnimal ModelAnimal Models and Related StudiesAnimalsAnnual ReportsAreaAssayBioassayBiological AssayBiological TestingBlood PlasmaClinicalClinical EvaluationClinical ResearchClinical StudyClinical TestingClinical TrialsClinical Trials NetworkContraceptive AgentsContraceptivesContractorD-NorgestrelData BasesDatabasesDevelopmentDevelopment and ResearchDevicesDocument TypeDrug FormulationsDrug KineticsDrug PrecursorsDrugsEndocrineEnrollmentEquipmentEvaluationFecundabilityFecundityFertilityFormulationGoalsGood Manufacturing ProcessGood manufacturing practiceGovernmentHumanHuman ResourcesIND FilingIND applicationIND packageIND submissionIn VitroIndividualInvestigational New Drug ApplicationInvestigatorsLevonorgestrelMaintenanceManpowerManuscriptsMedicationMetabolicMethodsMicrosomesMissionModelingModern ManNICHDNational Institute of Child Health and Human DevelopmentOvulationPK/PDPharmaceutical AgentPharmaceutical PreparationsPharmaceuticalsPharmacodynamicsPharmacokineticsPharmacologic SubstancePharmacological SubstancePhasePlasmaPlasma SerumPlayPreparationPro-DrugsProcessProdrugsProductionProgram DevelopmentProtocolProtocols documentationQualifyingR & DR&DReport (document)ReportingReproductive PhysiologyResearchResearch PersonnelResearch SupportResearchersReticuloendothelial System, Serum, PlasmaRoleSafetyServicesSpermSpermatozoaStudy modelsSystemTestingToxic effectToxicitiesToxicokineticsToxicologyUpdateWorkanalogandrogenicbasebasescandidate identificationchemical synthesisclinical developmentclinical lotclinical testdata basedesigndesigningdevelopmentaldrug candidatedrug developmentdrug lot productiondrug/agentenrollgood laboratory practiceimprovedin vitro Assayin vivol-Norgestrellot productionmanufacturemodel of animalnew chemical entitynew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnon-human primatenonhuman primatenovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypersonnelpharmaceuticalpharmacokinetics and pharmacodynamicspopulation healthpre-clinicalpre-clinical safetypre-clinical studypreclinicalpreclinical safetypreclinical studypreparationsproduct developmentprogramsrecruitreproductive outcomeresearch and developmentresearch clinical testingsafety studyscreeningscreeningssocial rolesperm cellsperm functionstability testingzoosperm

Applications closed.

Description preview

Within the Division of Population Health Research (DiPHR), the Contraceptive Development Program (CDP) at NICHD supports research to identify and develop compounds that can safely and reversibly modulate human reproductive physiology such as ovulation, sperm production, or sperm function with the goal of enabling individuals to better manage…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →

Explore more

📍 More grants in UNITED STATES🏷 More NIH opportunities🏷 More US Federal opportunities🏷 More Research Grant opportunities🏢 All nih_reporter opportunities
NICHD: R&D: ANDROGENIC, ANABOLIC, AND PRECLINICAL SAFETY STUDIES: NON-SEVERABLE — SRI INTERNATIONAL | UNITED STATES | Au | Dev Procure